Suzanne L. Elliott
Chief Scientific Officer, Deputy CEO of Q-Pharm, Australia
Biography
Suzanne Elliott is the Operations Manager, Chief Scientific Officer and Deputy CEO of Q-Pharm, a Brisbane-based clinical trials company. She has a PhD in molecular oncology from QUT/ Mater Hospital and a post-doctoral career in developing a prototypic vaccine for Glandular Fever with the QIMR Berghofer Eptein Barr Virus group. Subsequent roles at Vaccine Solutions and as the QIMR Berghofer Regulatory Affairs Manager, involved immunotherapy trials for post-transplant lymphoproliferative disease, Hodgkin’s Disease, malaria, prostate cancer and melanoma. Suzanne has qualifications in Drug Development from the University of New South Wales and is an accredited Research Trainer in Good Clinical Practice. Currently the Q-Pharm Scientific and Operations Manager she has responsibility for oversight of ‘all of company’ clinical trial project management and with special interests in early phase adaptive drug design, malaria challenge studies, vaccine studies and research ethics.
Abstract
Abstract : Recruitability and Retention: The Challenges of Vaccine Trial design
Speaker Presentations
Speaker PPTs Click Here